Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX01V with Microsoft SMTPSVC(5.0.2195.1600);
	 Wed, 11 Jul 2001 11:49:27 -0800
Received: from corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.1600);
	 Wed, 11 Jul 2001 13:48:00 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a825275c0a86ee241c@corp.enron.com> for <mswerzb@exchange.enron.com>;
 Wed, 11 Jul 2001 13:46:25 -0600
Received: from roxette.org ([211.51.84.8])
        by mailman.enron.com (8.10.1/8.10.1/corp-1.06) with ESMTP id g343Bbl45174
        for <MIKE.SWERZBIN@ENRON.COM>; Wed, 11 Jul 2001 14:45:31 -0500 (CDT)
Received: from ezagenda.com (ezagenda-com-bk.mr.outblaze.com [205.158.62.181])
	by roxette.org with esmtp
	id B5CC62A68A for <MIKE.SWERZBIN@ENRON.COM>; Wed, 11 Jul 2001 20:21:34 +0100
From: "Fidgeted G. Pancaking" <jcisaac@ezagenda.com>
To: MIKE.SWERZBIN <MIKE.SWERZBIN@ENRON.COM>
Subject: hey MIKE.SWERZBIN From $1.40 to $2.25 In 10 days. Promotions starting again!!!
Date: Wed, 11 Jul 2001 20:21:34 +0100
Message-ID: <101001c4f1a6$0c16811c$91ca3630@ezagenda.com>
MIME-Version: 1.0
Content-Type: text/plain
Content-Transfer-Encoding: 7bit
X-Priority: 3 (Normal)
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook, Build 10.0.4510
Importance: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1106
X-RAV-AntiVirus: This message has been scanned for viruses on roxette.org

Hello MIKE.SWERZBIN

Happy New Years, 

INVESTMENT ALERT … 
EMERGING BIOTECH COMPANY SOON TO RELEASE GROUND BREAKING MEDICAL DEVICE 

If your smart You will take 5 minutes to read this email and go check out the facts.
It's Time for you to have the most Profitable year of your life. 

When I mean check out the facts go look at the Month of December, promotions started on the 9th the stock went
From $1.40 to $2.25 In 10 days. Thats right .85 in 10 days.

There has never been a better time than now, the Holidays are over and world wide promotions  are beggining again.

INVESTMENT ANAYSIS........... 

In Vivo Medical Diagnostics, Inc. (Stock Symbol OTC: IVVO)
Short-Term Target: $2.80
12-Month Target: $4.20
Recommendations: Very Strong Buy
Long Term Outlook: Excellent 

In Vivo Medical Diagnostics, Inc (Stock Symbol OTC: IVVO) is finalizing its first ground-breaking portable medical device,
the Prothrombin Time Monitor, that measures changes in the magnetic fields of blood on a molecular level. 
This is critical for patients undergoing anticoagulation therapy after heart attacks and strokes.
This measurement is now portable and is used in real time to achieve optimal medication levels,
which is essential for successful treatment. IVVO has recently announced their joint effort with Inverness Medical Innovations
a leading manufacturer and marketer of rapid diagnostic products in order to complete development of the Prothrombin Time Monitor for its clinical trials.
Prothrombin Testing is a massive market and continues to grow with projections in excess of $150 million in 2005 and over $500 million by 2010.
IVVO is poised to capitalize on this significant opportunity. Don’t miss out on the near term upside potential in IVVO! 











Fresh as a daisy. 





Risk adverse traders take note.

Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the 
Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, 
objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements.” 
Please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein. 
This newsletter is neither a registered investment advisor nor affiliated with any broker or dealer. This newsletter is not affiliated with In Vivo Medical Diagnostics. 
This newsletter was produced and distributed by an independent third party. The third party was compensated  to express and distribute his opinion through this E-mail. 
All statements made are our express opinion only and should be treated as such. We may own, buy and sell any securities mentioned at any time. 
This report includes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. 
These statements may include terms as "expect", "believe", "may", "will", "move","undervalued" and "intend" or similar terms. 
PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose money from investing in Penny Stocks.







A fool uttereth all his mind. . The geek shall inherit the earth. . Half a loaf is better than none. . As you go through life, make this your goal, watch the doughnut and not the hole. .  
Two cannot fall out if one does not choose.   
  
One picture is worth a thousand words.   

An eye for an eye and a tooth for a tooth. . Do right and fear no man. . Few words and many deeds. . Empty vessels make the most sound. .  
If you don't say it you will not have to unsay it.   
  
He who hesitates is lost. . A journey of a thousand sites begins with a single click.  Facts do not cease to exist because they are ignored. .


